Type 2 Diabetes

You have been found to have higher-than-normal blood sugar levels (either mildly high fasting sugar, mildly high sugar after eating, or early type 2 diabetes) based on a specific blood sugar test. If you have early type 2 diabetes, you must either be taking no diabetes medication, or be taking just one type of oral…

You have been diagnosed with Type 2 diabetes, as defined by World Health Organisation guidelines. Your blood sugar control level (measured by an HbA1c blood test) is between 7.0% and 9.0% at your first visit. You have been taking a tablet or pill to help manage your blood sugar for at least 6 months, and that…

You have been diagnosed with type 2 diabetes You have been diagnosed with heart or cardiovascular disease You have been taking diabetes medication continuously for at least 8 weeks before joining the trial

You have been told you have "impaired glucose tolerance" (a condition where blood sugar is higher than normal but not yet diabetes) and are not taking any diabetes medication, OR you have Type 2 diabetes and are being treated with one or more specific diabetes medications (such as metformin alone, metformin combined…

You must have been diagnosed with type 2 diabetes and currently be taking two specific diabetes medications: metformin and a sulphonylurea (a type of diabetes pill). Your HbA1c (a blood test showing average blood sugar levels over the past few months) must be between 7% and 10.5%. Your fasting blood sugar level…

You have been diagnosed with type 2 diabetes for at least 6 months before the screening visit. You are currently taking at least 1000 mg of metformin per day, and your dose has not changed in the last 3 months. You are currently taking at least 100 mg of sitagliptin per day, and your dose has not changed in the last 3…

You have been diagnosed with Type 2 Diabetes within the last 24 months Your HbA1c (a blood test that measures average blood sugar levels over time) was between 6.5% and 7.5% at the first visit You have not previously taken any medication for diabetes Your body weight falls within a certain healthy range —…

You have been diagnosed with Type 2 diabetes Your HbA1c blood sugar level (a measure of average blood sugar over 2–3 months) is between 7.0% and 10.0% You are already taking Metformin at a dose of at least 1500 mg per day, taken twice daily You are 18 years of age or older Your body mass index (BMI, a measure of body…

You are aged 70 years or older and have been diagnosed with type 2 diabetes that is not well controlled with your current diabetes medications You are willing and able to sign a consent form agreeing to take part in the trial

You have been diagnosed with type 2 diabetes. Your blood sugar is not well controlled, meaning a recent blood test (called an HbA1c) showed a result between 7.0% and 10.5%. You are 30 years of age or older with a history of a heart or blood vessel problem, OR you are 50 years of age or older with a high risk of…

You must be willing to sign a consent form agreeing to take part in the trial before any assessments begin. You must have been diagnosed with Type 2 Diabetes. You must be 60 years of age or older when you sign the consent form. You must have been taking a stable dose of a long-acting (basal) insulin for at least 4…

You are 65 years old or older and have been diagnosed with type 2 diabetes that is not well controlled by your current diabetes medications Your current diabetes treatment includes either no insulin at all, or only a long-acting (basal) insulin as your only insulin type You have agreed to take part and signed a…

You have been diagnosed with type 2 diabetes (based on World Health Organization guidelines) for at least 1 year before the screening visit. You have been using a long-acting (basal) insulin plus at least one mealtime (bolus) insulin injection for at least 90 days before screening, OR you have been using a premixed…

You are 18 years old or older at the time of signing the consent form. You have been diagnosed with type 2 diabetes for at least 6 months before the screening visit. Your HbA1c (a blood test that measures average blood sugar levels over the past 2-3 months) is between 8.0% and 10.5%. Your body mass index (BMI, a…

People who have been diagnosed with type 2 diabetes. People who have already received treatment with a device called the Endogenex System. People who have agreed to take part in a separate program called the Endogenex PULSE Registry.

People who were in the sham (inactive) control group of the ReCET Study and completed their 12-month check-up visit. People whose HbA1c (a measure of average blood sugar over time) is between 7.0% and 10.5%. People with a body mass index (BMI) below 40 kg/m². People who agree not to donate blood while taking part in…

People who have been diagnosed with type 2 diabetes People who are 18 years of age or older People with a body mass index (a measure of body weight relative to height) above 18.5 People who are either not currently taking any diabetes medication, or who are only taking metformin, and who are willing to be randomly…

You are 18 years old or older You have been diagnosed with Type 2 diabetes for at least 12 months You have been taking a certain type of diabetes medication (called an SGLT2 inhibitor and/or GLP-1 receptor agonist) for at least 3 months, or these medications have been offered to you in the past (confirm with trial…

People who are 18 years of age or older People who have been diagnosed with Type 2 diabetes People who have persistent pain, meaning pain that is present on more days than not for at least 3 months People whose average pain severity scores 3 or higher on a standard pain measurement tool called the Brief Pain Inventory…

You have a Body Mass Index (BMI) between 30 and 50, and you weigh no more than 159 kg (350 lbs) at the time of screening You have tried to lose weight through lifestyle changes (such as diet or exercise) at least once before, without success You have no significant health issues found at your screening appointment…

Men who have been diagnosed with type 2 diabetes (based on World Health Organization standards) — note that only men are being included in this trial to avoid the influence of the menstrual cycle on stomach emptying results People with a Body Mass Index (BMI) between 28 and 38 kg/m² People whose HbA1c (a blood sugar…

You are 40 years old or older You have been diagnosed with type 2 diabetes Your medical scans are clear enough to be used by the study's imaging system (confirm with trial site) Your genetic risk score can be calculated using your available information (confirm with trial site)

You are between 18 and 60 years old (male or female) You are considered generally healthy by the study doctor Depending on which part of the trial you join: you have a body weight in the normal-to-healthy range (Parts 1), are significantly overweight (Parts 2 and 3), or have been diagnosed with type 2 diabetes (Part…

People who have been diagnosed with type 2 diabetes People whose HbA1c blood sugar level (a measure of average blood sugar over several months) was between 7.5% and 10.5% at their screening appointment People who have been managing their diabetes with diet and exercise alone, a stable dose of metformin, an SGLT2…

You are able to give yourself the study drug by injection, or have someone trained to help you if you have vision or physical limitations You have been diagnosed with type 2 diabetes, your HbA1c (a measure of average blood sugar) is between 6.5% and 10%, and you have been on a stable diabetes pill regimen for at least…

Anyone aged 18 or older, of any gender identity, regardless of sex assigned at birth People with a Body Mass Index (BMI) of 35 or higher (a measure of body weight relative to height) People without type 2 diabetes, meaning they have no history of it and a blood sugar (HbA1c) reading below 6.5% People with type 2…

People who have been diagnosed with Type 2 Diabetes for at least 90 days before the screening appointment People whose Type 2 Diabetes is not well controlled through lifestyle changes alone, or who have been on a stable diabetes medication routine People whose blood sugar control levels (measured by a test called…

People who have been diagnosed with type 2 diabetes for at least 90 days before the screening visit People who are on a stable treatment plan that includes background insulin and at least one other blood sugar-lowering medication People whose HbA1c (a measure of average blood sugar levels over time) is between 7% and…

People who have been diagnosed with type 2 diabetes (as defined by the National Diabetes Data Group) People who have a normal heart and blood vessel check-up result People who have not smoked for at least 1 year before joining Healthy volunteers with no known medical problems Healthy volunteers with a normal heart and…

You have been medically diagnosed with Type 2 diabetes within the last 2 years You have regular access to a computer

People who have been diagnosed with type 1 or type 2 diabetes. People between the ages of 25 and 65. Both men and women are welcome to apply. People from a variety of ethnic backgrounds are encouraged to participate. People who are able to attend 2 visits scheduled within a 2 to 4 week period, with each visit lasting…

People who took part in the Inter99 Baseline examination.

People who developed diabetes after age 30, or who developed diabetes before age 30 and have tested negative for certain immune markers (autoantibodies) that are linked to Type 1 diabetes. People who were diagnosed with diabetes during pregnancy (through an obstetric or maternity department).

People who took part in the original Diabetes Prevention Program study and are still living. For the Brain Imaging part of the study only: participants who are aged 55 or older and do not have any reasons that would prevent them from having an MRI scan (such as being unable to lie flat, having claustrophobia, or…

The person must be alive at the time their information is reviewed for the study. The person must be 18 years of age or older, and under 76 years of age, at the time their information is reviewed. The person must have had an in-person or virtual visit with a primary care doctor at a Parkland clinic within the last 18…

Currently pregnant and have been diagnosed with gestational diabetes (a type of diabetes that develops during pregnancy) Aged 18 years or older Have had contact with the Kaiser Permanente Northern California (KPNC) Regional Perinatal Service Center Able to communicate in English

People who have been diagnosed with diabetes. People who are not up-to-date with bowel cancer screening, based on their medical records — for example, those who have not had a stool blood test in the last year, a flexible bowel scope examination in the last four years, or a full bowel examination (colonoscopy) in the…

People between 25 and 75 years old. People who have had type 2 diabetes for more than 1 year. People who speak English or Spanish. People whose A1c (a blood sugar level measured over the past few months) was 8% or higher within the past 6 months — the trial team may adjust this requirement depending on how recruitment…

People who are 40 years of age or older. People who have type 2 diabetes, as well as people who do not have type 2 diabetes. People who are able to give their informed consent to participate. People who can read and speak English.

People from Oaxaca who are between 30 and 70 years old. People who attend the Nutrition outpatient clinic at the Oaxaca Hospital President "Benito Juárez," who were diagnosed no more than one year ago, and who agree to take part by signing a consent form. People who have been diagnosed with uncontrolled type 2…

People with moderate to severe erectile dysfunction, based on a specific questionnaire score below 17 (called the IIEF-5 score). People who have already tried at least two types of previous treatments for erectile dysfunction without success. People who have had nerve-sparing surgery in the pelvic area (such as…

People who have been diagnosed with a condition called MASLD (a type of fatty liver disease), confirmed by evidence of fat in the liver, limited alcohol intake (less than 140 grams per week for females or less than 210 grams per week for males), and at least one feature of metabolic syndrome (such as high blood…

Speaks and reads English Is between 18 and 75 years old Has been diagnosed with type 2 diabetes Receives outpatient care from one of the partnering clinics Lives in the community (for example, not in a nursing home or care facility) Has been prescribed at least one diabetes medication Owns a mobile phone Speaks and…

People who are 18 years of age or older People who have completed a health-related social needs screening questionnaire as part of a primary care visit People who have been diagnosed with type 2 diabetes, along with high blood pressure and/or high cholesterol, as recorded in their medical billing records People who…

People who have been clinically diagnosed with Type 2 Diabetes. People whose HbA1c (a blood sugar measurement over time) is between 6.5% and 8.5%. People who have been on a stable dose of diabetes tablets for at least 6 months. People aged 25 to 80 years old. People who have previously not been able to tolerate…

People who have received outpatient (non-hospital) care within the participating health system in the past 12 months. People who have been diagnosed with type 2 diabetes mellitus. People whose most recent HbA1c blood sugar measurement (taken within the last 6 months) was 7.5% or higher, indicating blood sugar levels…

People who have been diagnosed with type 2 diabetes. People who are 60 years of age or older. People who live in a nursing home or similar long-term care facility in Portugal. People who are able to understand what the study involves and agree to take part by giving their informed consent. People whose diabetes…

People with a Body Mass Index (BMI) over 25 and up to 35 (this is a measure of body weight relative to height that falls in the overweight to moderate obesity range). People whose blood cholesterol level is 250 mg/dl or below and whose triglyceride (blood fat) level is 200 mg/dl or below. People with type 2 diabetes…

People between 18 and 74 years old. People who have recently been diagnosed with type 2 diabetes. People who are members of Kaiser Permanente Northern California and receive their care in a participating service area. People aged 45 years or younger who have an HbA1c (a blood sugar level measurement) above 8%. People…

Men between 18 and 75 years of age. People who have been diagnosed with type 2 diabetes, based on World Health Organization criteria. People who have a history of smoking for at least one year. People who score 4 or higher on a standard test that measures nicotine dependence (called the Fagerström Test for Nicotine…

People who are willing to voluntarily sign a consent form agreeing to take part. People aged between 18 and 75 years old (inclusive), male or female. People who have been diagnosed with type 2 diabetes according to World Health Organization (WHO) standards for more than 6 months. People who have been using premixed…

People who are between 18 and 65 years old People who can read and write People who have scored above 5 on the Pittsburgh Sleep Quality Index (PSQI), a standard sleep quality questionnaire (confirm with trial site) People who have been diagnosed with Type 2 diabetes for at least one year People who own their own…

People who are members of Kaiser Permanente Northern California (KPNC) and are between 19 and 44 years old People who have recently been diagnosed with type 2 diabetes within the last 6 months People who are a caregiver to at least one child under 18 years old at the time of their diabetes diagnosis People who…

Women between 18 and 45 years old People who have been diagnosed with polycystic ovary syndrome (PCOS) using a standard set of medical guidelines called the Rotterdam criteria, or people who do not have PCOS and are participating as healthy comparison volunteers People who are willing and able to agree to take part…

You are between 18 and 75 years old (inclusive) You are able to understand what the study involves and are willing to sign a consent form You have been diagnosed with the condition this trial is studying, based on recognised medical or diagnostic standards Your current treatment (whether medication or another type of…

The person speaks and reads English. The person is between 18 and 75 years old. The person has been diagnosed with type 2 diabetes. The person receives outpatient care from one of the clinics partnering with this trial. The person lives in the community (for example, not in a nursing home or care facility). The person…

Adults aged 18 years or older. People who have been diagnosed with Type 2 Diabetes. People who receive their care at Family Medicine Units in the Mexican states of Coahuila, Jalisco, or Veracruz. People who are willing to take part in the study voluntarily. People who are able to understand what the study involves and…

People aged 18 or older. People who have been diagnosed with schizophrenia, another psychotic disorder, or bipolar disorder. People who are enrolled in a clinical pharmacist population management program for serious mental illness within Kaiser Permanente Northern California.

People who were previously enrolled in and completed the evaluation phase of a specific earlier study called the EPSONIP trial (NCT03864510). People who are 18 years of age or older. People who have given their informed consent to take part in the trial.

People who have pre-diabetes that has not yet been treated, with or without fatty liver disease People who have type 2 diabetes that has not yet been treated, with or without fatty liver disease Men and women between the ages of 18 and 74 People who have signed a form agreeing to take part in the trial

People who identify as Native Hawaiian or Pacific Islander People aged 18 years or older People who have been told they have, or believe they have, at least one of the following: overweight or obesity (a BMI of 25 or higher), pre-diabetes or diabetes, high blood pressure, or high cholesterol People who are able to do…

Adults between 18 and 50 years of age. People who are classified as generally healthy with no serious medical conditions (known as ASA Class I status — confirm with trial site if unsure what this means). People who have been diagnosed with Type 2 diabetes, with a blood sugar control measure (called HbA1c) between 5.5%…

Men and women are eligible to participate. Participants must be between 30 and 55 years of age. Blood sugar control levels (measured by a test called HbA1c) must fall within a specific range — at or above 8.5 but below 10 (confirm with trial site for exact units used). Body weight relative to height (BMI) must fall…

People who are 18 years of age or older People who have been diagnosed with prediabetes or Type 2 diabetes People whose HbA1c (a measure of average blood sugar over time) is below 8%, and whose body mass index (BMI) falls between 18 and 40, calculated from height and weight People who are willing to wear a blood sugar…

People who have been diagnosed with type 2 diabetes for more than one year, are able to use a smartphone, and are willing to sign a consent form agreeing to take part.

Adults between the ages of 30 and 80 who have been diagnosed with type 2 diabetes within the last 5 years. People whose type 2 diabetes medication has stayed the same for at least 8 weeks before signing up for the trial. People whose blood sugar control (measured by a test called HbA1c) falls within a specific range —…

People enrolled in the Korean National Health Insurance Service (NHIS) with valid insurance coverage during the year being assessed (for the main analysis). Adults aged 19 years or older as of January 1 of the relevant assessment year, covering years 2013 to 2023 (for the main analysis). People enrolled in the Korean…

People who have been diagnosed with type 2 diabetes. People whose most recent blood sugar control test (called HbA1c) showed a result above 8% within the last 6 months. People who have had a clinic visit in the past 6 months. People who screened positive for food insecurity based on a standard 6-question survey about…

Adults aged 18 years or older who are registered patients at Hospital Clínica Nova, including both men and women, who have a confirmed diagnosis of type 2 diabetes based on the hospital's standard clinical guidelines. People who receive their diabetes care through the Metabolic Clinic at the hospital.

Healthy volunteers between the ages of 20 and 59, or people who have one or more of the following health factors: a body weight considered overweight or higher (BMI over 25), higher-than-normal blood pressure (systolic above 130 mmHg), abnormal cholesterol or fat levels in the blood, or blood sugar levels in the…

People who have been diagnosed with Type 2 diabetes (both women and men may be eligible). People whose body weight falls within a certain range — specifically, a Body Mass Index (BMI) between 18 and 40 at the time of screening. People who have low magnesium levels in their blood, as measured by a specific blood test…

People who have been clinically diagnosed with type 2 diabetes, with that diagnosis recorded in their family doctor's electronic medical record. People who do not have insurance coverage for medications.

The decision to start taking Rybelsus was made by the patient (or their legal representative) and their doctor before and separately from any decision about joining this study. The person has type 2 diabetes and their doctor has decided to start them on Rybelsus based on its approved use in Korea. The person has given…

People who are willing to take part voluntarily and agree to sign and date a consent form confirming this. People who have been diagnosed with type 2 diabetes and whose blood sugar levels have not reached the recommended target through diet, physical activity, and taking the highest tolerated dose of metformin (kept…

Adults aged 18 to 80 years old. People who have been diagnosed with an acute ischemic stroke (a stroke caused by a blocked blood vessel in the brain) classified as either a complete or partial front-of-brain circulation stroke, based on a recognised stroke classification system. People who have been diagnosed with…

People aged 19 years or older People who have been diagnosed with type 2 diabetes People who identify as Black (self-reported) People who receive their care at one of the study sites and have had at least one visit there in the past year People who have a moderate to severe level of diabetes-related emotional…

People who have been diagnosed with type 2 diabetes and a diabetes-related condition that affects how the digestive system moves food through the body. People whose blood sugar control measure (a test called HbA1c) is below 11.0%.

People who have been diagnosed with type 2 diabetes (not an autoimmune type or a rare inherited form of diabetes). People whose average blood sugar level (HbA1c) is 7.0% or above and whose diabetes medications have been stable for a period of time. People whose average blood sugar level (HbA1c) is between 6.0% and…

Adults between 18 and 65 years old, either male or female. People who have never previously taken any blood sugar-lowering treatments, including prescription medications or traditional Chinese medicine products that lower blood sugar. People with prediabetes, defined by having a fasting blood sugar level between 6.1…

People who have been diagnosed with type 2 diabetes, confirmed by two separate fasting blood sugar readings above 1.26 g/l. People aged 18 or older. People with a Marshall score (a health assessment measure) of 3 or below (confirm with trial site). People who live in the Nouvelle-Aquitaine region of France. People who…

Adults between 18 and 65 years old (inclusive) People whose waist measurement meets the central obesity threshold set out in Chinese obesity guidelines (2019) (confirm with trial site) People whose blood sugar test results meet the criteria for impaired glucose tolerance (a pre-diabetes condition where blood sugar is…

People who are able to understand what the trial involves and are willing and able to give written consent to participate. Male participants aged 18 to 55 years (inclusive) at the time of signing the consent form. People with a body weight of at least 50.0 kg and a body mass index (BMI) between 23.0 and 35.0 kg/m²…

Adults between 18 and 65 years old, of any gender. People with a body mass index (a measure of body weight relative to height) between 27 and 50. People who are able to understand written and spoken English and/or Spanish. People with signs that their body is not responding well to insulin, shown by any of the…

People who are willing to take part and have signed the consent form agreeing to participate. Chinese adults aged 18 to 75 years (inclusive), male or female. People who have been clinically diagnosed with type 2 diabetes for more than 6 months. People whose HbA1c (a measure of average blood sugar levels over time) is…

People who are older than 18 years of age. People who have been diagnosed with Type 2 diabetes. People who have been admitted to hospital for more than 48 hours.

People who receive their care at one of the NexusHealth hospitals in Belgium (a list of affiliated hospitals is available at the link in the official criteria). People who have been diagnosed with type 2 diabetes. People who are enrolled in either the Diabetes Care Trajectory or the Diabetes Convention (group B) in…

People who currently live in the same household as a main study participant. People who are willing to take part in the study's data collection activities. People who can read and speak English fluently.

Consent to participate must be given before any trial-related activities begin Adults aged 18 years or older at the time of signing the consent form, of any gender People with a BMI of 30 or above, with or without weight-related health conditions, or a BMI between 25 and 29.9 with at least one weight-related health…

People who are older than 60 years of age. People who have not been diagnosed with Type 2 diabetes based on World Health Organization criteria. People who speak and understand Danish, as this is required for accurate cognitive testing. People who are able to give informed and written consent to participate.

Adults aged 18 to 70 years who are first-generation Asian Indian immigrants living in the community, are part of a married couple where both partners participate, can read and write English, and are comfortable using technology.

People who are overweight or obese, of Chinese background, are willing to sign a consent form, can receive injections under the skin, fully understand what the trial involves including possible side effects, and are able to follow the rules set out in the trial plan. People who are male or female, aged between 18 and…

Adults who have medical records available in the western region of Saudi Arabia

People with a body mass index (a measure of body weight relative to height) of 23 or above (or 22 or above for people of Asian background), but below 45. People whose blood sugar level (measured by a test called HbA1c, which reflects average blood sugar over a few months) is between 5.7% and 8.0%, and who are not…

People with type 2 diabetes who attend regular outpatient check-ups every 3 months People aged between 35 and 65 years old (this age range is required because the liver measurement tool used in this trial is not considered accurate for people younger than 35 or older than 65)

People who are between 30 and 65 years old People who have diabetes People who are attending an outpatient clinic (a regular clinic visit, not a hospital stay) People who are willing and able to cooperate with the study requirements Both men and women are eligible People of Egyptian nationality

People aged 40 to 65 years old, of any gender. People who have type 2 diabetes confirmed in their medical records, and who are able to keep their medications the same (same type, number, and dose) throughout the study. People whose HbA1c blood sugar level is between 6.5% and 9.5%, based on a blood test taken at the…

People who are between 18 and 65 years old. People who have been diagnosed with Type 2 diabetes for at least 6 months. People who do not have any psychiatric disorders or mental health conditions. People whose hemoglobin A1c (a measure of blood sugar control over time) is below 8 mmol/mL. People who are able to carry…

People aged 50 years or older, of any gender. People who have been diagnosed with type 2 diabetes for at least 6 months before the screening visit, with a blood sugar control measure (HbA1c) between 7.2% and 10.0% at screening. People who have been taking a stable dose of one to three approved blood sugar-lowering…

People who have been diagnosed with diabetes according to the 1999 World Health Organization (WHO) diagnostic standards.

People who are over 20 years old and have been diagnosed with Type 2 Diabetes by a doctor. People whose body mass index (a measure of body weight relative to height) is greater than 24, or whose waist measurement is greater than 90cm (for men) or greater than 80cm (for women). People who have been tested with a home…

People with type 2 diabetes who are receiving care at the Akdeniz University Hospital Endocrinology and Metabolic Diseases Outpatient Clinic. People who have one or more diabetic foot risk factors, classified as category 2 or 3 under the IWGDF (International Working Group on the Diabetic Foot) Risk Classification…

People who have been diagnosed with type 2 diabetes recently (less than 10 years ago). People who are between 40 and 65 years of age.

People who are 18 years of age or older.

People who are over 18 years old People who have been medically diagnosed with high blood pressure, type 2 diabetes, or high cholesterol (or a combination of these) for at least 6 months, as recorded in their medical records People whose medication-taking habits have been assessed as low adherence using a specific…

Adults (men or women) between the ages of 30 and 75 years. People who have been diagnosed with Type 2 diabetes. People whose daily insulin requirement is 0.7 units per kilogram of body weight per day, or 50 units per day, whichever is the lower amount. People whose blood test for a specific antibody called GAD…

The person must have signed an informed consent form at the time of joining the study. The person must be between 30 and 70 years old. The person must have been diagnosed with Type 2 diabetes (according to American Diabetes Association standards) for at least 6 months. The person must have stable blood sugar control…

People who have been diagnosed with type 2 diabetes. People who are between the ages of 40 and 65. People who are able to walk on their own without assistance. People who are willing to exercise at least 2 days per week as required by the study (for those in the exercise groups). People who are able to communicate and…

Adults aged 18 years or older at the time of signing the consent form. People with a body mass index (BMI) between 18.0 and 35.0 — a measure of body weight relative to height — falling within this range on either end. People who have been clinically diagnosed with type 2 diabetes before the screening visit. People…

Adults aged 18 or older who are considered overweight or obese based on their height and weight (including a lower weight threshold for people of Asian background). People whose blood sugar levels fall into a range that is higher than normal but not yet at the level of a diabetes diagnosis — this may be shown through…

People aged 18 to 75 years old (inclusive) at the time of screening, of any gender. People who have been diagnosed with Type 2 Diabetes for at least 8 weeks before screening, and who have not taken any diabetes medications in the 8 weeks before screening. People whose HbA1c (a blood sugar measurement taken over…

Women who are pregnant and have type 2 diabetes. Women receiving care at one of the four pregnancy and diabetes centres in Denmark. Women who are 18 years of age or older.

People who have been diagnosed with type 2 diabetes by a doctor People who are between 19 and 65 years of age People whose body mass index (BMI) falls between 20 and 35 kg/m² (BMI is a measure based on height and weight) People who are managing their diabetes with tablets or other non-insulin oral medications, and are…

Adults (men and women) who have had a confirmed diagnosis of type 2 diabetes for at least one year. People aged 18 or older. People whose score on a diabetes-related emotional stress questionnaire (called the Diabetes Distress Scale) is above 2.0 on at least one section of the questionnaire. People whose blood sugar…

Adults between 18 and 65 years old People who have been diagnosed with type 2 diabetes within the last 5 years People whose HbA1c (a measure of average blood sugar levels over time) is between 7.0% and 10.0% People with a body mass index (BMI) between 25 and 40 kg/m² People who are either taking metformin only (no…

People who have been diagnosed with type 2 diabetes using standard diagnostic criteria set by the American Diabetes Association (ADA). People whose HbA1c blood sugar level (a measure of average blood sugar over several months) is 7% or above but below 9%. People whose diabetes medications have not changed for at least…

Adults between 18 and 65 years of age. People who have been diagnosed with Type 2 Diabetes. People whose most recent HbA1c blood sugar measurement was 8% or higher, taken within the last 6 months (this is a measure of average blood sugar levels over time). People who speak and understand Arabic and/or English. Both…

People between the ages of 40 and 70 years old. People who are generally in good health based on their medical history and a physical check-up. People without diabetes or pre-diabetes (based on American Diabetes Association guidelines, meaning blood sugar levels are in a healthy range and no blood sugar-lowering…

People diagnosed with type 2 diabetes (a condition mainly caused by the body not responding well to insulin or not making enough of it), confirmed by blood sugar test results or diabetes symptoms meeting specific levels set out in Chinese clinical guidelines. People aged 18 to 65 years old (inclusive), of any gender.…

People between the ages of 18 and 65. People who are currently taking oral (tablet or capsule) medication to manage diabetes. People who are able to use a smartphone and have access to the internet. People who can read, write, and speak Turkish. People who do not have any difficulties with communication skills…

People who are between 35 and 65 years old People who have been diagnosed with type 2 diabetes People whose blood sugar levels are considered under control People who scored fewer than 8 correct responses on a standard foot sensation test using a specific testing tool (called a 5.07 Semmes-Weinstein monofilament)…

People who are 60 years of age or older. People who have had their oral health measurements recorded, whether or not they have Type 2 Diabetes.

People who are 40 years of age or older. People who live in the Peel region of the Greater Toronto Area. People who do not have any chronic conditions that would affect their ability to take part in the study. People who are overweight, have a large waist measurement, and have at least one self-reported risk factor…

A person must have a confirmed diagnosis of type 2 diabetes, based on China's 2024 diabetes guidelines. Men must be aged 50 or older; women must be aged 45 or older and have been through menopause for more than 2 years. A person must have had diabetes for more than 10 years, or have at least one of the following…

Women who have gone through menopause, meaning their periods have stopped for at least 12 months, confirmed by a hormone blood test People aged between 45 and 70 years old People who have been diagnosed with type 2 diabetes for more than one year People whose type 2 diabetes is managed through diet and lifestyle…

Men and women living in the United States who meet the legal age of adulthood — this means age 18 or older in most states, age 19 or older in Nebraska and Alabama, or age 21 or older in Puerto Rico. People who are able and willing to travel to Washington DC for two body scan appointments (called DXA scans) — one…

People who have been diagnosed with type 2 diabetes and live in Upper Egypt. People who are older than 18 years of age. People who have agreed and given their written consent to take part in the trial.

People who are currently in hospital because of a lung or respiratory infection. People who have been diagnosed with type 2 diabetes. People who are between 18 and 90 years of age. People who are able to communicate (by speaking or other means) and can understand Mandarin or Taiwanese. People who are willing to take…

People who are male and have been diagnosed with Type 2 diabetes. People who are between 30 and 60 years old. People who are at least 155cm tall (this is to ensure safe and comfortable use of the cycling equipment). People whose HbA1c level (a measure of average blood sugar over recent months) is between 6% and 8%.…

People aged between 10 and 21 years old. People who have been diagnosed with type 2 diabetes, based on a doctor's diagnosis or medical records. People who have had type 2 diabetes for at least 3 months. People whose HbA1c blood sugar level is 7% or above (this is a measure of average blood sugar over time). People…

Adults aged 18 or older (male or female). People who have been diagnosed with type 2 diabetes. People who have been diagnosed with chronic kidney disease (CKD) with specific kidney function and protein levels in their urine, measured during the screening period (confirm with trial site for exact values). People whose…

People who are able to understand the trial and are willing to sign a consent form agreeing to take part. People who are 18 years of age or older. People who have been diagnosed with type 2 diabetes. People whose blood sugar has been managed only through diet and exercise, with no diabetes or blood sugar-lowering…

People who are willing and able to give their informed consent to take part in the trial. People who are able and willing to follow all trial requirements throughout the study. Men or women between 18 and 70 years old who do not have major health conditions. Adults who have been clinically diagnosed with type 2…

People who have successfully enrolled in the VDOP program and are ready to begin it, and who are not currently on insulin therapy People who have been clinically diagnosed with type 2 diabetes People whose HbA1c (a blood sugar level test result) was between 8.0% and 12.0% within the last 3 months People whose doctor…

People who have been diagnosed with type 2 diabetes.

People who have been diagnosed with type 2 diabetes. People whose HbA1c (a blood test that measures average blood sugar levels over about 3 months) is between 7.0% and 11.5%. People whose Body Mass Index (BMI) is 20 or above at the time of their screening appointment. People whose weight has been stable (within 5% up…

People who have been diagnosed with Type 2 Diabetes. People between the ages of 40 and 65 years old. People who are willing to take part in the study and sign a consent form after having the research process fully explained to them.

People who are at least 18 years old People who have type 2 diabetes People who have recently been started on semaglutide or tirzepatide by their doctor People who are able to speak and read English

People aged 18 or older at the time of signing the consent form, of any gender. People who have been diagnosed with type 2 diabetes for at least 90 days before the screening visit. People who have been managing their diabetes with diet and exercise alone for at least 90 days before the screening visit. People whose…

People aged 18 or older at the time of signing the consent form, of any gender. People who have been taking a stable daily dose of metformin (at least 1,500 mg per day, or the highest dose they can tolerate which must be at least 1,000 mg per day) for at least 90 days before screening — either metformin alone, or…

People who have been diagnosed with Type 2 diabetes, based on World Health Organization diagnostic standards. People aged between 50 and 75 years old. People whose blood sugar control measure (called HbA1c) falls between 6.5% and 9.0%. People whose bone density scan results show a T-score below -1 in the spine, hip…

People who have been diagnosed with Type 2 Diabetes for more than 3 months People between the ages of 30 and 56 years old People who are able to read and follow written instructions People who have access to a digital device such as a smartphone or tablet People who are in a stable health condition

People who have been diagnosed with type 2 diabetes for more than 1 year but less than 15 years. People who have been taking at least one diabetes tablet at a stable dose for 3 months or longer. People whose blood sugar control (measured by a specific blood test called HbA1c) is above a certain level at the screening…

You must be willing and able to sign a consent form agreeing to take part in the study. You must be 18 years old or older. You must have been diagnosed with type 2 diabetes. Your recent blood sugar control test (HbA1c) must show a result between 7% and 9%, your fasting blood sugar must be at or below a certain level…

Participants must fall into one of two groups: healthcare practitioners and researchers working in diabetes research and/or clinical care, or people living with type 2 diabetes. All participants must be 18 years of age or older.

People who have signed an informed consent form agreeing to take part. Men and women between 18 and 80 years old (inclusive). People who have been formally diagnosed with type 2 diabetes, confirmed using recognised diagnostic guidelines. People whose most recent HbA1c blood sugar level was above 6.5% (a common measure…

People who have been diagnosed with type 2 diabetes, confirmed by specific blood sugar measurements (A1c of 6.5% or higher, or fasting blood glucose of 126 mg/dL or higher) People who are currently not very physically active, based on a low score on a standard activity questionnaire People who have access to an…

People with Type 2 diabetes who are between 18 and 80 years old, able to give their informed consent to participate, diagnosed with Type 2 diabetes for more than 6 months, and whose diabetes medications have been stable for more than 6 months. Healthy individuals (without diabetes) who are between 18 and 80 years old…

People who were diagnosed with type 2 diabetes at least six months ago, are currently being treated with insulin and/or diabetes tablets, and have a blood sugar control level (HbA1c) of 7% or higher. People who can speak and read Turkish, own a smartphone, use the WhatsApp app, and have access to the internet. People…

People who score 4 or above on a standard questionnaire used to measure neuropathic (nerve-related) pain. People who are 18 years of age or older. People who do not have a psychiatric illness. People who are able to answer all of the study questions. People who speak Turkish.

The trial is looking for 120 participants in total — 60 Chinese Americans and 60 Vietnamese Americans. Adults aged 18 or older who live independently in the community. People who have been diagnosed with type 2 diabetes. People whose HbA1c (a blood sugar measure taken over roughly 3 months) is above 7.0%. People who…

Adults between the ages of 20 and 60 years. People who are already scheduled to receive a steroid injection into the spine (either in the neck or lower back area) at a pain clinic. People who are able to understand and use a small wearable device that tracks blood sugar levels continuously (called a CGM device).

A parent, legal guardian, or the child themselves (where age-appropriate) must agree to take part and sign the required consent forms before any study activities begin. The parent or legal guardian must sign and date the official consent form, following local requirements. The child must sign and date an assent form…

People between the ages of 18 and 70 years old (inclusive). People who have symptoms that may be related to diabetes — such as unusual thirst, increased hunger, frequent urination, or unexplained weight loss — and whose doctor has recommended a glucose tolerance test (a test where blood sugar is measured after…

People aged between 18 and 80 years old at the time of joining; any gender is eligible. People who have been diagnosed with type 2 diabetes (according to Chinese Medical Association guidelines) for at least three months. People who have been diagnosed with a specific type of heart failure — either "heart failure with…

People who have been diagnosed with type 2 diabetes by a doctor People who have also been diagnosed with a liver condition related to metabolic health (known as MAFLD) People whose blood sugar control measure (HbA1c) falls between 6.5% and 9.5% People whose body mass index (a measure of weight relative to height)…

People who are 60 years of age or older. People whose Timed Up and Go test result takes more than 10 seconds to complete (a test that measures how long it takes a person to stand up, walk a short distance, and return to their seat). Both men and women are eligible. People who have been diagnosed with type 2 diabetes…

People who were diagnosed with diabetes when they were aged 18 or older but younger than 40.

People aged 19 to 75 years old at the time of signing the consent form. People with a body mass index (BMI) between 20 and 35 at the screening visit (BMI is calculated by dividing weight in kilograms by height in metres squared). People who were diagnosed with type 2 diabetes at least 12 weeks before the screening…

People who are at least 35 years old. People whose HbA1c (a blood sugar average test) result is above 7.0%. People who are currently using one or more insulin injections. People whose medications have remained the same for the 3 months before joining the study. People who have been on insulin for at least 3 months at…

Adults aged 18 or older who have been diagnosed with type 2 diabetes and have been on the same diabetes treatment for at least three months. People whose blood sugar control measure (HbA1c) is between 7% and 10% while taking Metformin, with or without other diabetes tablets. People for whom a doctor has determined…

People aged between 18 and 45 years. People who have been diagnosed with Type 2 Diabetes. People who are able to read and write in the language used in the study. People who have access to the internet and to a digital device such as a smartphone, tablet, or computer. People who do not have hearing, speech, or severe…

People who have been diagnosed with type 2 diabetes for at least 12 months. People who have not been regularly physically active before joining the trial. People who have a good understanding of hypoglycaemia (low blood sugar). People who are over 18 years of age. People who are able to understand and agree to take…

People who have been diagnosed with type 2 diabetes. People who are 65 years of age or older. People who are scheduled for planned (non-emergency) surgery to remove a liver tumor, where the operation is expected to take more than 2 hours. People who have had a specific full-body scan called a PET/CT scan within the…

Adults aged 18 or older People who have been found to have prediabetes (slightly raised blood sugar levels) or Type 1 or Type 2 diabetes People with elevated levels of cholesterol or fats (lipids) in their blood, based on specific blood test results People who are either not taking any cholesterol-lowering medication…

People aged between 18 and 65 years. People who can read, write, understand, and speak Turkish. People who have been diagnosed with type 2 diabetes for at least one year. People who are currently taking diabetes tablets and/or insulin for their diabetes. People who have had a blood sugar control measurement (called…

Adults aged 18 or older People who have been diagnosed with type 2 diabetes People whose HbA1c (a blood test that shows average blood sugar levels over the past few months) is between 6.5% and 12.0% People whose fasting C-peptide level (a blood test that shows whether the pancreas is still producing insulin) is 0.5…

People who have prediabetes, meaning their blood sugar levels are higher than normal but not yet in the diabetes range (based on a specific blood test result or a sugar-loading test result within a certain range) People who have given their written agreement to take part in the trial

People who are 18 years of age or older People who are able to give their consent to participate after being informed about the trial People who have been diagnosed with type 2 diabetes People who are planning to fast during Ramadan

People who are willing to sign a consent form before the study begins, understand what the study involves including possible side effects, and are able to follow the rules and restrictions set out in the study plan. People who are between 18 and 75 years old (inclusive) at the time of signing the consent form, of any…

People who are 18 years of age or older. People who are having urgent (unplanned/emergency) abdominal surgery. People who have been diagnosed with diabetes, either before coming to hospital or newly diagnosed when admitted. People who are considered at high risk of developing a surgical site infection (a wound…

Women between the ages of 18 and 35 years old People who have been diagnosed with polycystic ovary syndrome (PCOS), either the type that affects insulin levels or the type that does not People who have results available from baseline hormone blood tests and a sugar-processing test (called an oral glucose tolerance…

People of any sex (as recorded at birth) who are 18 years of age or older at the time of signing the consent form. People who were diagnosed with type 2 diabetes at least 180 days before the screening visit. People whose HbA1c (a blood test that shows average blood sugar levels over several months) falls between 7%…

People who have been diagnosed with Type 2 Diabetes for at least 12 weeks, and who have been on a stable dose of metformin (either alone or combined with a type of diabetes medication called an SGLT2 inhibitor) for at least 12 weeks before the screening visit. People whose blood sugar control measure (called HbA1c, a…

People who are pregnant with one baby (not twins or more) People who have been diagnosed with Type 1 or Type 2 diabetes People who have been using an insulin pump continuously under the skin for at least 2 months before their due date People who have shown the ability to manage their own insulin, are familiar with how…

People who have been diagnosed with Type 2 diabetes for at least 1 year People whose blood sugar control measurement (HbA1c) was 6.5% or higher before the study start date People who started semaglutide or another blood sugar-lowering medication before January 1st, 2023 People who have been seen by a specialist…

People aged 18 to 70 years old at the time of signing the consent form. People who have been diagnosed with type 2 diabetes. People who are willing to take part voluntarily and sign a consent form (if someone cannot read the form, an impartial witness must be present and also sign). People who are newly diagnosed with…

People who have prediabetes classified as "high risk," meaning their fasting blood sugar level falls between 100–125 mg/dL AND their HbA1c (a measure of average blood sugar over time) falls between 5.7–6.4%. People aged 30 to 74 years old. People whose Body Mass Index (BMI) is between 23.0 and 35.0 kg/m². People who…

People who are Saudi nationals, of any gender (male or female) People aged between 45 and 60 years old People with a body mass index (BMI) between 25 and 30 (considered slightly overweight) People who have not taken antibiotics in the last six months For the "cases" group (people with diabetes): People who have been…

People who are 18 years of age or older. People who have been diagnosed with a solid cancerous tumour, confirmed through laboratory tissue testing. People for whom a doctor has planned treatment using one or two immune checkpoint inhibitor (immunotherapy) medications, whether for advanced, post-surgery, or pre-surgery…

A person must give their informed consent before any trial-related activities, including any steps taken to check whether they are suitable for the trial. The person must be living in the community (not in a care facility or hospital). The trial is open to both men and women. The person must be aged 65 or older at the…

People who are female. People aged between 48 and 58 years old. People who are in the menopausal transition phase, meaning either pre-menopause or peri-menopause (the period leading up to menopause). People who have been diagnosed with Type 2 Diabetes. People who have and regularly use a smartphone with internet…

Adults aged 18 to 75 years (both men and women are eligible). People with a body mass index (BMI) between 22 and 35, which is a measure of body weight relative to height. People whose HbA1c blood sugar level (a measure of average blood sugar over the past few months) is between 7.0% and 10.5%. People who have been…

Adults aged 18 or older People with a body mass index (BMI) of 27 or above who also have health conditions related to their weight, OR people with a BMI of 35 or above regardless of other conditions People whose treating doctor has determined that the medication tirzepatide is clinically appropriate for them People…

People aged between 18 and 45 years old. People with a BMI between 18 and 25, with a stable weight over the previous 6 weeks. People who are in good physical and psychological health, with no diagnosed medical conditions or illnesses. Women must have regular menstrual cycles that fall within accepted variation limits…

People who are 18 years of age or older. People who are being treated in hospital for type 2 diabetes or diabetes caused by steroid medication, and whose treatment plan includes using insulin after leaving hospital.

Healthy men or women who are between 18 and 45 years old (inclusive) People with a Body Mass Index (BMI) between 19.0 and 26.0, where men weigh at least 50 kg and women weigh at least 45 kg People who have no plans to become pregnant or donate sperm from the time of signing the consent form until 3 months after the…

People who are 18 years of age or older People who are Qatari or of Arab background People who have been admitted to hospital for a serious heart condition, either a sudden blockage or reduced blood flow to the heart (Acute Coronary Syndrome), or a sudden worsening of heart failure (Acute Heart Failure) People who…

Participants must be healthy men or women. Participants must be between 18 and 45 years of age (inclusive). Participants must have a Body Mass Index (BMI) between 19.0 and 26.0, and men must weigh at least 50 kg while women must weigh at least 45 kg. Participants must have no plans for pregnancy or sperm donation from…

Adults aged 18 to 65 years, of any gender People who have recently been diagnosed with type 2 diabetes and have not yet taken any diabetes medication People whose HbA1c blood sugar level at the screening visit is between 7.0% and 9.0% (a blood test result that reflects average blood sugar over roughly 3 months) People…

Adults aged 18 years or older, of any gender. People who have been diagnosed with overweight or obesity, with a body mass index (BMI) of 24 or higher (BMI is a measure based on height and weight). People who are willing and able to use a smartphone app for managing their weight. People who are willing and able to sign…

People who are 18 years of age or older People whose systolic (top number) blood pressure reading is 130 mmHg or higher, confirmed across at least two separate visits at least one day apart but within seven days, based on an average of six measurements total People with a HbA1c blood sugar level of 6.5% or higher (a…

Adults aged 18 or older who have been diagnosed with both type 2 diabetes and chronic kidney disease A blood sugar control measurement (HbA1c) between 7.0% and 11% A urine test result (albumin-to-creatinine ratio) between 300 and 5000 mg/g, which indicates a certain level of kidney protein leakage A body mass index (a…

People aged 19 years or older at the time of the screening visit. People who weigh at least 50 kg (or at least 45 kg for females) and have a body mass index (BMI) between 18.0 and 30.0 at the screening visit. People who do not have any significant long-term or inherited health conditions, and who show no concerning…

People who are patients at the University of Miami Pediatric Endocrinology Clinic People who have been diagnosed with obesity (a body mass index at or above the 95th percentile for their age) and Type 2 Diabetes (a blood sugar measurement known as Hemoglobin A1c above 6.5%) Children and teenagers between the ages of 5…

Adults between 18 and 65 years old People who have been diagnosed with type 2 diabetes People who are currently being seen and monitored by a doctor at one of the participating medical centres People who have access to the internet and own a smartphone People who are able to give their informed agreement to take part…

People who have been clinically diagnosed with Type 2 Diabetes. People who are between 40 and 65 years of age. People who are not currently being treated with insulin. People whose diabetes medications have remained unchanged for at least 3 months. People who are able to understand the study information and agree to…

Adults between the ages of 18 and 70 years old People who are able to give informed consent to participate in the study People who have completed the NHS Path to Remission programme, achieved diabetes remission (meaning their blood sugar levels have returned to a healthy range below a certain threshold), and have been…

People who are 18 years of age or older at the time of signing the consent form. People who are currently taking tirzepatide, prescribed by their own doctor (independently of this registry), for an approved or accepted use such as type 2 diabetes, insulin resistance, obesity (with or without related metabolic…

People who have signed the study's consent form. Men or women are eligible to participate. People aged between 40 and 70 years old at the first visit. For the Low-risk group: People who are generally healthy, free from ongoing or long-term illness, and who do not have the cardiovascular risk conditions listed in the…

Adults aged 18 to 65 years, male or female. A liver fat content of 10% or more, measured by a specific type of MRI scan within the 3 months before joining the trial. A diagnosis of type 2 diabetes. A blood sugar control measure (HbA1c) between 7.0% and 10.5%. A fasting blood sugar level between 7.0 and 13.3 mmol/L. A…

Adults aged 18 years or older People who have been diagnosed with Type 2 Diabetes People who have been attending a Jordanian Ministry of Health healthcare facility for at least six months and attending regular check-up visits there People who are able to check their own blood sugar levels at home, or who are able to…

Men, or women who have gone through menopause (confirmed by a blood test showing FSH at or above 30 U/l), are the population this trial is looking for. People with a body mass index (BMI) between 25 and 40, which is a measure of body weight relative to height. People who do not currently smoke tobacco, or who stopped…

People who identify themselves as being of Indian or African ancestry. People who were diagnosed with diabetes between the ages of 18 and 47 years old. People who have been diagnosed as having type 2 diabetes. People who have been hospitalised for a dangerous build-up of acid in the blood related to diabetes…

Adults between 18 and 65 years of age People who have not previously been diagnosed with type 2 diabetes or high blood pressure People who receive their regular healthcare at a Mexican Social Security Institute (IMSS) or IMSS-Bienestar primary health centre People who are willing and able to give their informed…

People aged between 18 and 75 years old (inclusive). People who have been diagnosed with Type 2 Diabetes. People who have been taking a stable dose of a specific type of diabetes medication called an SGLT-2 inhibitor (either alone or combined with one other diabetes tablet) for at least one month before screening, but…

Adults aged 18 or older who are able to communicate clearly and think clearly. People who have been diagnosed with either Type 1 or Type 2 Diabetes, based on World Health Organization diagnostic standards. People whose diabetic feet have been classified as high-risk, based on the 2023 standards set by the…

People who are able to understand and are willing to sign a consent form, and who agree to follow all study requirements. People aged between 18 and 60 years old (inclusive). People who meet at least one of the following weight-related criteria: a body mass index (BMI) of 24 or above; or a waist measurement of 90 cm…

Adults over 18 years of age People who have been diagnosed with type 2 diabetes and chronic kidney disease at an early-to-moderate stage, with a higher-than-normal amount of protein (albumin) in their urine People with a body mass index (a measure of body weight relative to height) of 25 or above People who are taking…

People who are willing to take part and sign a consent form agreeing to join the study. People aged between 18 and 60 years (inclusive), of any gender. People who have been diagnosed with type 2 diabetes within the last 5 years, have not taken any blood sugar-lowering medication in the past 3 months, and have an HbA1c…

Adults between 18 and 60 years of age. People with a body mass index (BMI) between 30 and just under 40, which is considered a measure of body weight relative to height. People who have been diagnosed with type 2 diabetes for less than one year. People who are non-smokers, or who have not smoked for more than 3…

People between the ages of 20 and 35, as defined by the World Health Organization. People who may be at risk of diabetes based on a family history of the condition or certain lifestyle habits, as reported by themselves. People who are willing to take part in a mobile health program as part of the study. People who own…

Adults aged 18 years or older, of any sex People who are eligible for or enrolled in a social security scheme People who have given written consent to take part in the study People who do not have a prior diagnosis of high blood pressure (arterial hypertension) People who have not been on stable heart or blood vessel…

Adults aged 18 or older People who do not have diabetes at the time of joining the trial People who are having part or all of their pancreas surgically removed at the study centre People for whom the required health and metabolism-related information is available, as needed for the relevant part of the study People…

People who have been clinically diagnosed with type 2 diabetes, based on World Health Organization standards or other relevant local guidelines. People whose HbA1c (a measure of average blood sugar levels over time) was between 7.0% and less than 9.5% at the screening appointment. People who plan to fast during the…

The patient has been diagnosed with Type 1 Diabetes (T1D) according to World Health Organization (WHO) guidelines. The patient has been living with Type 1 Diabetes for 6 months or longer. The patient has no difficulties with thinking, awareness, or reading ability. The patient agrees to take part in the study. The…

People who are willing and able to take part in the study, understand what it involves, and are able to sign a consent form before any assessments begin. Adults aged 18 to 80 years (note: in Korea the minimum age is 19; in Indonesia it is 18). People who have been diagnosed with type 2 diabetes, based on American…

Adults aged 18 years and older who are willing to take part and sign a consent form agreeing to participate. People of any sex, whether male or female. People who have been diagnosed with type 2 diabetes for more than 6 months, based on recognised international diagnostic standards. People who have been taking…

A signed consent form must be completed before any study-related activities begin. The decision to start treatment with the insulin icodec must have been made by the person (or their legal representative) and their treating doctor, separately from and before any decision about joining this study. People who are male…

People who were male at birth People aged between 18 and 40 years old People who have been diagnosed with type 2 diabetes People who have been diagnosed with erectile dysfunction People who have been prescribed tadalafil (a medication for erectile dysfunction) People who have a sexual partner who is willing to fill…

The person must be willing and able to give written consent to take part in the study. The person must be 22 years of age or older. The person must have a body mass index (BMI) between 30 and 50 kg/m². The person must have an HbA1c (a blood sugar level measured over time) between 7.5% and 10.5%. The person must have…

People who have been diagnosed with type 2 diabetes. People who meet the medical criteria for mild cognitive impairment (early-stage memory or thinking difficulties that are more than normal aging but not dementia). People aged between 40 and 75 years old, of any gender. People whose HbA1c (a blood test measuring…

People who have a confirmed diagnosis of Type 2 diabetes that is being managed with insulin injections under the skin. People who currently have an acute (sudden or active) infectious disease of any kind. People who are 18 years of age or older. People who are willing and able to follow the trial's plan and…

People who have been diagnosed with diabetes mellitus (DM). People who are over 40 years of age. People who have been diagnosed with peripheral neuropathy (nerve damage, usually causing pain, numbness, or tingling) where symptoms have lasted for more than 3 months. People who have reduced blood flow in the lower…

Adults aged 18 to 65 years old People living with obesity and insulin resistance (a condition where the body doesn't respond well to insulin) People with a Body Mass Index (BMI) between 30 and 45 kg/m² Men with a waist measurement of 102 cm or more, or women with a waist measurement of 88 cm or more People with a…

People aged 18 to 75 years at the time of signing the consent form, of any gender. People who have been diagnosed with Type 2 Diabetes according to 2019 World Health Organization (WHO) standards, with a blood sugar control measure called HbA1c between 7.5% and 11.0%. People whose blood sugar has not been adequately…

People who are male or female (past menopause) and aged 35 years or older. People who have been diagnosed with Type 2 diabetes, confirmed by a specific blood sugar marker (HbA1c at or above a certain level, as defined by the World Health Organization). People who are willing and able to give their agreement to…

A person must have signed a consent form before taking part in any study-related activities. The decision to start treatment with the insulin icodec must have been made by the person (or their legal representative) and their treating doctor before and separately from any decision to join this study. People aged 18…

People aged 18 to 75 years old at the time of signing the consent form, of any gender. People who have been diagnosed with type 2 diabetes for at least 3 months, based on 2019 World Health Organization criteria. People who have been managing their diabetes through diet and exercise only, without any blood…

People between the ages of 50 and 75 years old People who score 5 or higher on a standard diabetes risk screening questionnaire developed by the American Diabetes Association People who report that a family member has been diagnosed with dementia or Alzheimer's disease People who own and use a smartphone (either…

Men or women between 40 and 65 years old Of Chinese, Malay, or Indian ethnicity Having a Body Mass Index (a measure of body weight relative to height) between 23.0 and 32.0 Having blood sugar levels that suggest prediabetes, based on specific fasting blood glucose and HbA1c (a 3-month average blood sugar measure) test…

Adults aged between 18 and 65 years old People who have been diagnosed with Type 2 Diabetes People whose HbA1c blood sugar measurement falls between 6.5% and 13.0% (a test that shows average blood sugar levels over the past few months) People who are not currently using insulin to manage their diabetes People who have…

Adults between 18 and 75 years of age People who have been diagnosed with type 2 diabetes for more than 6 months, based on the International Diabetes Federation's diagnostic criteria People whose type 2 diabetes is not well controlled, with a blood sugar measure called HbA1c between 7.5% and 10.5% People whose…

People who are over 18 years old. People who have chronic kidney disease, shown by kidney function test results below a certain level (less than 60 ml/min/1.73 m²) on at least two separate tests within the past six months. People who are being treated with a type of insulin called basal insulin, a basal-bolus insulin…

People with type 2 diabetes that is being managed with diet and exercise, and who are also taking metformin and/or a long-acting (basal) insulin. People whose blood sugar control measure (HbA1c, a 3-month average blood sugar test) is above 6.5% and no higher than 11.0% at the time of screening. People who weigh at…

Adults between 20 and 78 years of age. People who are able and willing to sign a written consent form agreeing to take part. People who fall into one of the following groups: those having surgery to remove part or all of the pancreas for a non-hormonal pancreas condition; those with a specific type of pancreatic…

People who are willing to sign a consent form, receive injections under the skin, understand what the study involves, and follow the rules set out in the study plan. Men aged between 18 and 50 years old (inclusive) at the time of signing the consent form. People who weigh at least 50 kg and have a Body Mass Index…

The person must have signed a consent form agreeing to follow the requirements of the trial. The person must have completed the Week 72 visit in the previous related study (Study 20210184). The person must not have permanently stopped taking the study treatment during that previous study. The person must be enrolled…

Adults between 18 and 80 years of age People who have been diagnosed with type 2 diabetes for at least 6 months People whose HbA1c blood sugar level was above 8% in the last 3 months (this is a measure of average blood sugar control) People who are currently taking one or more diabetes tablets or pills People who are…

People who have been diagnosed with both type 2 diabetes and obesity. People aged between 30 and 65 years. People whose Body Mass Index (BMI) falls between 30 and 40 kg/m² (a measure of body weight relative to height). People whose HbA1c (a blood test showing average blood sugar levels over roughly 3 months) is above…

Adults aged 18 to 65 years (male or female). People with a recent type 2 diabetes diagnosis — meaning diagnosed within the last 3 years and not having taken any blood sugar-lowering medications in the past 3 months — with blood sugar levels confirmed by specific test results at the time of diagnosis. People with a…

Adults aged between 21 and 70 years. People who have been diagnosed with type 2 diabetes. People who agree to eat durian for 2 weeks as part of the study. People with a body mass index (a measure of body weight relative to height) between 25 and 40 kg/m².

Adults aged 18 or older at the time of screening. People who have at least one of the following metabolic conditions: a body mass index (a measure of body weight relative to height) of 23 or above; a waist measurement of 80 cm or more (for women) or 90 cm or more (for men); a fasting blood sugar or average blood sugar…

Adults aged 18 or older, of any gender People who have been diagnosed with type 2 diabetes for at least 3 months, based on Chinese national diabetes guidelines People who have also been diagnosed with a liver condition called metabolic dysfunction-associated steatotic liver disease (MASLD), confirmed through liver…

People aged 18 years or older. People who are permanent residents of Dali City and have lived there for at least six consecutive months in a row. People who are registered as rural residents. People with no known history of diabetes. People who meet at least one high-risk factor for type 2 diabetes as defined in the…

People aged between 30 and 80 years (male or female) who have been diagnosed with Type 2 Diabetes. People whose diabetes is not well controlled, shown by a blood sugar marker (HbA1c) of 7.0% or higher. People living with obesity, measured either by a Body Mass Index (BMI) of 25 or higher (using the threshold set for…

People aged 18 years or older, of any gender People who are able to understand the study information and sign a written consent form People who are able to travel to the Clinical Research Unit (the study location) People who are willing and able to avoid eating or drinking after midnight before their study appointment…

People aged between 18 and 70 years old. People of any gender. People who meet the NHS criteria for weight-loss (bariatric) surgery. People who have been diagnosed with either prediabetes (impaired glucose regulation) or type 2 diabetes, based on World Health Organization guidelines from 2011. People with diabetes…

You do not have dementia You are willing and able to sign a consent form agreeing to take part in the trial You have had at least 6 years of education Your blood sugar levels meet the specific requirements for the group you would be placed in (confirm with trial site)

You are currently pregnant

You are between 18 and 40 years old Your Body Mass Index (BMI) is between 25 and 40 (this is a measure of body weight relative to height) You have been diagnosed with PCOS based on having at least two of the following: unusual hair growth or acne; irregular or absent periods (periods more than 35 days apart, fewer…

You are between 18 and 70 years old You have been diagnosed with type 2 diabetes within the last five years You have family support available to you You do not have serious or disabling complications from diabetes

People who are between 18 and 65 years old at the time of their surgery People with a Body Mass Index (BMI) over 35 (a measure of body weight relative to height) People who have been approved by their doctor for weight-loss surgery, specifically sleeve gastrectomy or gastric bypass People who fall into one of three…

People who have been diagnosed with pre-diabetes, shown by specific blood sugar test results: a HbA1c (average blood sugar level) between 5.7% and 6.4%, or fasting blood sugar readings of 100–125 mg/dL on two separate days, or a blood sugar level of 140–199 mg/dL two hours after drinking a sugary drink during a…

Men or women between 18 and 65 years old at the time of screening People with fasting blood sugar below 100 mg/dl and a two-hour blood sugar reading below 140 mg/dl (these are measured through specific blood tests — confirm with trial site) People with a body mass index (BMI) between 24 and 40 People whose weight has…

You are willing and able to give your consent to take part in the study You are aged between 18 and 75 years old (inclusive) You have been diagnosed with stable type 2 diabetes, confirmed by your GP's records along with either a glucose tolerance test or a specific blood sugar level result

People who have no concerns about their own memory or thinking ability People who show no signs of cognitive problems on formal testing, as reviewed by an expert panel People with a Clinical Dementia Rating (CDR) score of 0 or 0.5 (a standard measure of memory and thinking; confirm with trial site) People whose blood…

People who have a medically appropriate reason to receive a CRT device implant, an electrophysiology (heart rhythm) examination, or a pulmonary vein ablation procedure People who are of legal adult age in their country People who are willing and able to provide written consent to participate People who are physically…

Men and women between 18 and 60 years old People with a BMI of 35 or higher People who either have type 2 diabetes (confirmed by blood sugar or HbA1c testing, or currently taking diabetes medication) or do not have diabetes (confirmed by normal blood sugar and HbA1c results) People who are already on a waiting list…

People who are 18 years of age or older People who have been diagnosed with at least one of the following conditions: type 2 diabetes, high blood pressure, heart failure, or chronic kidney disease People who are willing and able to sign a written consent form to participate in the registry

People aged 19 or older People who are able to sign a written consent form agreeing to take part People who are able to travel to Omaha, Nebraska in person twice a year for blood sample collection People diagnosed with type 2 diabetes within the last 3 years (based on specific blood sugar test results or a doctor's…

People who are aged 65 years or older People who have been living in the Nanshan district of Shenzhen for at least 5 years People who are Chinese

People who are between 60 and 80 years old (male or female) People who have pre-diabetes or type 2 diabetes and are only managing it with certain oral medications (DPP-4 inhibitors, Sulfonylureas, and/or Metformin), with a blood sugar control level (A1C) below 8.0 — or people who have normal blood sugar levels and…

People who are 18 years of age or older People who have been diagnosed with diabetes mellitus, either based on a doctor's diagnosis or according to current diagnostic guidelines for diabetes Both males and females are eligible People who are willing and able to sign a written consent form People who are likely to…

People who are planning to have a type of weight-loss surgery called Roux-en-Y gastric bypass (RYGB) People aged between 18 and 80 years old People who have been diagnosed with type 2 diabetes or prediabetes People whose weight has been stable for at least 3 months People with a BMI (body mass index) of 30 or above…

People with a Body Mass Index (BMI) between 25 and 30 (considered overweight) People with a BMI of 30 or higher who also have metabolic syndrome (a cluster of conditions such as high blood pressure, high blood sugar, and abnormal cholesterol levels) People with a BMI of 35 or higher (considered severely obese)

You have been diagnosed with type 1 or type 2 diabetes, confirmed using standard medical guidelines. You are able to follow the study instructions and are expected to attend all required visits and complete all study steps. You agree to use reliable birth control during the study, and if you are a woman who could…

People aged between 21 and 70 years old People who have ongoing nerve-related pain in their legs and back People who are already planning to have a spinal cord stimulator (a device implanted to help manage pain) fitted People who have never previously had a spinal cord stimulator trial for pain People whose Body Mass…

You meet the NHS guidelines (NICE guidelines CG189) for weight loss (bariatric) surgery. You have been diagnosed with Type 2 diabetes. Your Body Mass Index (BMI) is above 30 kg/m² (confirm with trial site if unsure of your BMI).

You must be 18 years of age or older. You have been diagnosed with, or are suspected to have, a liver condition called NAFLD (a build-up of fat in the liver not caused by alcohol), confirmed by one of the following: a past liver biopsy showing NAFLD; a current or planned liver biopsy for suspected NAFLD supported by…

Men and women between 30 and 85 years old People with pre-diabetes, meaning their blood sugar levels are slightly above normal but not yet in the diabetes range (confirm with trial site for specific test values) People with normal blood sugar levels who could serve as a comparison group (confirm with trial site for…

People who have at least one of the following blood sugar concerns: high HbA1c levels, impaired fasting glucose, or impaired glucose tolerance — or who have already been diagnosed with Type 2 diabetes People who are able to communicate in English People who are 18 years of age or older

Women who are postmenopausal and between 55 and 65 years old Women with a Body Mass Index (BMI) — a measure of body weight relative to height — between 35 and 39.9 Women who have been postmenopausal for more than 2 years

Men and post-menopausal women with a body mass index (a measure of body weight relative to height) between 25 and 40 People aged between 45 and 74 years Women who have confirmed menopause, based on a specific hormone blood test result (FSH ≥ 30 U/l) People who do not smoke People who do little structured exercise —…

You must be an adult (18 years or older). You must be able to understand the information given about the trial and be able to agree or disagree to take part. You must have been diagnosed with type 2 diabetes and must NOT have heart failure at stage B or above. You must be covered by a social security (health…

People who do less than 1 hour of physical activity per week (considered sedentary) People with a BMI between 25 and 40 Both men and women, with or without type 2 diabetes, may be considered

Adults aged 18 or older People who have been diagnosed with type 2 diabetes according to World Health Organization diagnostic standards People whose heart health allows a specific type of low-radiation CT scan of the heart arteries to be performed at the start of the study People who are able to understand the purpose…

You have been diagnosed with type 2 diabetes

People aged between 19 and 80 years old. People who have been diagnosed with type 2 diabetes. People whose type 2 diabetes is not well controlled, with a blood sugar level (HbA1c) between 7.0% and 10.0% — this is a measure of average blood sugar over the past few months. People who have signed a form agreeing to take…

People who are already patients at the Wake Forest Infectious Diseases Specialty Clinic People who are living with HIV People who are 18 years of age or older People who are able to give their informed consent to participate

Adults aged 18 years or older who have been diagnosed with type 2 diabetes by a doctor, or who have a blood sugar marker (HbA1c) above 6.5% Adults aged 18 years or older who have not been diagnosed with any form of diabetes

You have been approved and have a scheduled date for weight-loss (metabolic) surgery at Vanderbilt University Medical Center You have a history of type 2 diabetes, high blood pressure, or high cholesterol/triglycerides You are willing and able to share personal information and provide biological samples (such as blood…

People in the high-risk group whose HbA1c blood sugar marker is 6.0% or higher and who have not yet been treated People in the high-risk group whose BMI (body mass index) falls at or above the 85th percentile for their age group People in the control group whose HbA1c blood sugar marker is 5.6% or lower (considered…

People of any gender are eligible. People who have been diagnosed with HIV. People who have been diagnosed with Type 2 Diabetes, OR people who are at high risk of developing Type 2 Diabetes — meaning they meet at least one of these conditions: a recent blood test showing blood sugar levels in the prediabetes range, a…

People who have recently had a type of heart attack called a STEMI (where a specific pattern shows up on a heart tracing) People aged 18 to 80 years People whose blood sugar control measure (HbA1c) is below 9.0% People who have been diagnosed with diabetes, based on an HbA1c of 6.5% or above and/or an abnormal blood…

People between 18 and 80 years old People who have been diagnosed with coronary artery disease (a condition affecting the heart's blood vessels) People diagnosed with type 2 diabetes, based on one of the following: a HbA1c (average blood sugar) result of 6.5% or higher, a fasting blood sugar level of 7.0 mmol/L or…

Pregnant women who have Type 2 diabetes or gestational diabetes (diabetes that develops during pregnancy) and need insulin to control their blood sugar levels during pregnancy.

People who are under 18 years old People who have been diagnosed with type 2 diabetes People whose HbA1c blood sugar level (a measure of average blood sugar over the past few months) is 6.5 or higher People who receive their diabetes care at the Rady Children's Hospital Diabetes Clinic

People who are native Pakistani Men between the ages of 35 and 60, or women between the ages of 35 and 65 People who are willing to give their consent to take part in the trial

People aged between 25 and 65 years old People with a body mass index (BMI) between 30 and 40 (a measure of body weight relative to height that falls in the obesity range) People who have been diagnosed with a liver condition called NAFLD (non-alcoholic fatty liver disease, where excess fat builds up in the liver)…

You have been diagnosed with type 2 diabetes You are between 18 and 64 years old Your body mass index (BMI) is 27 or higher (confirm with trial site if you are unsure of your BMI) Your yearly income is less than $47,520 You identify as Hispanic and/or Latinx You regularly check your blood sugar levels You have access…

People aged between 18 and 70 years old People who have been clinically diagnosed with type 2 diabetes People whose glycosylated hemoglobin (a measure of blood sugar control over time) is between 6.5% and 9.5% People who have either taken no diabetes medication, or only one oral diabetes tablet, in the past 6 months…

People who are able and willing to give their informed consent to participate. People who are older than 35 years of age.

Women aged 18 years or older Women who are pregnant with a single baby and are 14 weeks pregnant or less at their first obstetric appointment Women who have an established diagnosis of type 2 diabetes, confirmed by blood test results meeting specific thresholds (confirm with trial site for exact values) Women who are…

Adults aged 18 to 99 years People who are willing and able to provide written consent to participate People who have been diagnosed with at least one of the following conditions: Type 1 diabetes, Type 2 diabetes, Type 3 diabetes, a form of diabetes called Maturity Onset Diabetes of the Young (MODY), a form of diabetes…

People aged 65 or older who receive care from a local community health service centre. People who have been diagnosed with type 2 diabetes, confirmed by at least one of the following: typical diabetes symptoms with a high random blood sugar reading; a fasting blood sugar level of 7.0 mmol/L or higher (after no food or…

People aged 21 to 65 years at the time of enrolling in the study People diagnosed with type 2 diabetes, with blood sugar levels within a specific range (fasting blood glucose between 140–270 mg/dL), a blood sugar control marker (HbA1c) between 7.0% and 9.0%, triglyceride (blood fat) levels below 400 mg/dL, who have…

People aged 20 or older (male or female) with type 2 diabetes that is currently being treated People whose HbA1c blood sugar level falls between 6.0% and 10.0% at the screening visit People with a specific type of cholesterol problem called mixed dyslipidemia — meaning triglyceride levels between 200 and 499 mg/dL…

People who have type 2 diabetes that is being treated, with blood sugar control (HbA1c) measured between 6.0% and 10.0% at the screening visit. People who are male or female, aged 20 years or older. People who have a specific type of cholesterol problem (mixed dyslipidemia) while already taking a moderate-strength…

People who identify as African American People of any gender (male or female) People living in a medically underserved area or a designated rural area of South Carolina People aged 18 years or older People who were hospitalised, visited an emergency room, or visited an urgent care clinic due to COVID-19 at any point…

People who have been diagnosed with both type 2 diabetes and a liver condition called NAFLD (a build-up of fat in the liver not caused by alcohol) People aged between 18 and 75 years old People with a body mass index (BMI) between 18.0 and 35.0 People whose weight has been stable (changing by less than 4 kg) for at…

You are willing and able to sign a consent form agreeing to take part in the trial Your body mass index (a measure of body weight relative to height) is 25 or above, meaning you are classified as overweight or obese Your HbA1c blood sugar level (a measure of average blood sugar over the past few months) is at or above…

You identify yourself as Marshallese You are 18 years of age or older You have been diagnosed with type 2 diabetes, meaning your blood sugar level (HbA1c) is 6.5% or higher You have at least one family member who is willing to take part in the study alongside you

People who identify as Hispanic or Latino, of any race People who are registered patients at a federally qualified health center People who are 18 years of age or older People who have Type 2 diabetes with a blood sugar control measurement (HbA1c) above 7.5%, recorded in the last 90 days People whose primary care…

You are a man or woman living in the U.S. who meets the legal adult age in your state (18 or older in most states, 19 or older in Nebraska and Alabama, or 21 or older in Mississippi) You have previously been diagnosed with type 2 diabetes

Adults who have previously been diagnosed with type 2 diabetes

You are 18 years of age or older You have been diagnosed with diabetes

Adults aged 18 years or older People who speak Arabic People who are able to use a smartphone People who have been diagnosed with type 2 diabetes People whose blood sugar levels are not well controlled (specifically, an HbA1c level above 7.5%, which is a measure of average blood sugar over the past few months —…

People who have been newly diagnosed with type 2 diabetes, metabolic syndrome, obesity, or high blood pressure — based on the specific measurements described below — or who are already receiving treatment for one of these conditions. People with type 2 diabetes, which the trial defines as: two or more fasting blood…

You are attending a scheduled cardiology or diabetes/hormone specialist follow-up appointment You are willing to fast before having a blood sample taken You are between 40 and 85 years old (inclusive) You do not object to taking part in this research You agree to have your biological samples stored and used for…

You are 20 years old or older You have been diagnosed with pre-diabetes or diabetes You are from Taiwan, or you can speak and understand Mandarin or Taiwanese fluently You are not currently pregnant or breastfeeding You are able to use a smartphone to take photos of your meals and keep track of what you eat, either on…

People who identify as African American or Black People aged 18 or older People who screen positive for one or more social or life hardships using a standard health-related needs screening tool (such as issues with housing, food, transportation, or finances) People who have been told they have type 2 diabetes and…

Adults aged 18 to 65 years old People who have been diagnosed with Type 2 Diabetes People whose glycated hemoglobin (a measure of blood sugar control over time) is between 7% and 11% People who are overweight or obese, with a BMI between 25 and 40 People who are currently taking diabetes medication (tablets or…

People aged between 40 and 80 years old at the time of signing the consent form People who have had Type 2 diabetes for at least 5 years, with blood sugar levels (HbA1c) between 7.0% and 10.5% People with a Body Mass Index (BMI) of 25 or higher (considered overweight or obese) People who have two specific fatty…

You identify as Non-Hispanic African American You are over 18 years old You have a blood sugar (A1c) level above 7.5, which indicates poorly controlled blood sugar You own a working smartphone You complete a screening questionnaire about binge eating habits

People who have been diagnosed with type 2 diabetes and obesity

People who have been diagnosed with type 2 diabetes within the last 24 months, based on a doctor's assessment People aged 30 to 80 years old People whose HbA1c blood sugar level (a measure of average blood sugar over time) is between 6.5% and 11%, based on a test result from the last 6 months People who have access to…

You are willing and able to sign a consent form agreeing to take part in the study You are able to commit to following all study procedures for the full length of the study You are male or female, between 18 and 60 years old You have a diagnosis of Type 2 diabetes in your medical history Your blood sugar control…

You are between 40 and 65 years old (male or female) You have had type 2 diabetes for at least 3 years, with a blood sugar control level (HbA1C) between 7% and 10%, and you are already taking diabetes medications such as insulin, metformin, sulfonylureas, or SGLT2 inhibitors You are in a generally stable state of…

People who have a blood sugar control reading (called HbA1c) above a certain level, whether or not they are currently on medication for it People who were diagnosed with type 2 diabetes less than 6 years ago People with a body mass index (BMI) of 27 or higher (or 25 or higher for people of Asian background)

Non-smokers who are generally healthy, aged 18 to 55 (for Parts A–E) or 18 to 70 (for Parts F and G), of any gender People with a body weight in a certain range relative to their height — specifically a BMI of 19 to 35 (Parts A–E), or a BMI of 30 to 50 (Parts F and G) People whose kidneys are working at a sufficient…

People aged 19 to 65 years old (male or female) People who have been diagnosed with type 2 diabetes, with a blood sugar control reading (HbA1c) between 6.5% and 11%, managed through diet alone with no diabetes medications — or people who do not have type 2 diabetes at all (healthy volunteers) People who follow regular…

People who are physically located in Pakistan at the time of the trial People who are 18 years of age or older People who have been diagnosed with diabetes

Full-time primary care doctors or nurse practitioners who work at one of the participating health centres or group practices Providers who care for at least five patients diagnosed with type 2 diabetes People who have been diagnosed with type 2 diabetes for at least 6 months People whose type 2 diabetes is not well…

People who have been formally diagnosed with heart failure where the heart's pumping function is preserved (pumping more than 50% of blood out with each beat) People whose condition has been stable for at least 3 months, with no hospital admissions during that time People aged 65 or older People who are willing to…

People who are 18 years of age or older, of any gender People who have been diagnosed with type 2 diabetes People who have a complete medical history and full clinical records available People with type 2 diabetes who also have chronic kidney disease and have had a kidney biopsy, where the biopsy results gave a clear…

Adults aged 18 years or older People who have been diagnosed with Type 2 Diabetes and have an HbA1c (a blood sugar measurement) above 8.0 People who are current patients of the Family Healthcare Center at Reading Hospital Tower Health

You are an emergency patient who had a blood test showing an HbA1c result of 6.5% or higher (this is a measurement related to blood sugar levels over time). You live in New York City or Long Island. Your main language is English or Spanish. You are able to understand and agree to participate in the study on your own.

You have had a specific type of heart pump (called an LVAD — either a HeartWare or HeartMate 3 device) implanted at any point after 2010 You have been diagnosed with Type 2 diabetes You are currently taking any medication or treatment to manage your blood sugar levels It has been more than 3 months since your heart…

People between 18 and 65 years old People with a body mass index (BMI) of 35 kg/m² (a measure of body weight relative to height) People who have been diagnosed with Type 2 diabetes, based on Diabetes Canada's diagnostic criteria People who have been diagnosed without Type 2 diabetes, based on Diabetes Canada's…

Adults aged 18 years or older Both males and females are welcome to participate People from all racial and ethnic backgrounds are welcome People across a wide range of body weights and sizes People with or without a diagnosed condition called Polycystic Ovary Syndrome (PCOS) People who have had specific blood tests…

You are between 20 and 85 years old You are male or female and have been diagnosed with heart failure with symptoms (ranging from noticeable limitations during physical activity to severe symptoms at rest), and your doctor has recommended a heart tissue biopsy — this may also apply if you have already had a heart…

People between the ages of 30 and 75 with type 2 diabetes People with a Body Mass Index (a measure of body weight relative to height) between 21 and 45 People whose blood sugar control measure (HbA1c) falls between 7.0% and 11% People whose kidneys are working at a sufficient level, as measured by a test called eGFR…

You are between 30 and 65 years old at the time of joining the study You are not living in a care facility or institution (such as a nursing home) You are currently living in Puerto Rico, have lived there for at least the past year, and do not plan to move off the island within the next 3 years You are able to answer…